Bexxar regimen

From Wikipedia, the free encyclopedia

The Bexxar regimen is a combination of monoclonal antibodies used to treat certain types of non-Hodgkin lymphoma. The monoclonal antibody tositumomab is given with iodine I 131 tositumomab (a form of tositumomab that has been chemically changed by adding radioactive iodine). Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells.

[edit] External links

• Bexxar regimen entry in the public domain NCI Dictionary of Cancer Terms

This article includes text from the U.S. National Cancer Institute's public domain Dictionary of Cancer Terms